GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: BMS-936557 | MDX-1100
                                 Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Eldelumab (BMS-936557 and formerly MDX-1100) is a a fully human monoclonal antibody targeting the chemokine CXCL10 (a.k.a. interferon-γ-inducible protein-10 or IP-10) [1]. It is being investigated for its anti-inflammatory action in autoimmune conditions. BLAST peptide sequence analysis reveals exact matches with heavy and light chain variable regions claimed in patent US8258266, and identify eldelumab as clone 6A5 [1]. | 
| Classification  | |
| Compound class | Antibody | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 9746 | eldelumab | 
| Synonyms  | 
| BMS-936557 | MDX-1100 | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 463 | 
| Other databases | |
| GtoPdb PubChem SID | 315661132 | 
| Search PubMed clinical trials | eldelumab | 
| Search PubMed titles | eldelumab | 
| Search PubMed titles/abstracts | eldelumab |